This week we’re joined by Jacob Bell, a senior reporter for BioPharma Dive. In his role, Jacob covers the FDA, big pharma, and drugmakers. He has held positions at Industry Dive including reporter and associate editor and has reported for other notable outlets including The Deal, TheStreet, and McClatchy.

On the episode, Jacob tells us about pitches that grab his attention and ones that completely miss the mark, his preference for sources using bullets, his hopefulness for the future of journalism, and more.